Atorvastatin Pretreatment Ameliorates Mesenchymal Stem Cell Migration through miR-146a/CXCR4 Signaling.

Tissue Eng Regen Med

Department of Radiology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, 100020, China.

Published: October 2021


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: We previously found that atorvastatin (ATV) enhanced mesenchymal stem cells (MSCs) migration, by a yet unknown mechanism. CXC chemokine receptor 4 (CXCR4) is critical to cell migration and regulated by microRNA-146a (miR-146a). Therefore, this study aimed to assess whether ATV ameliorates MSCs migration through miR-146a/CXCR4 signaling.

Methods: Expression of CXCR4 was evaluated by flow cytometry. Expression of miR-146a was examined by reverse transcription-quantitative polymerase chain reaction. A transwell system was used to assess the migration ability of MSCs. Recruitment of systematically delivered MSCs to the infarcted heart was evaluated in Sprague-Dawley rats with acute myocardial infarction (AMI). Mimics of miR-146a were used in vitro, and miR-146a overexpression lentivirus was used in vivo, to assess the role of miR-146a in the migration ability of MSCs.

Results: The results showed that ATV pretreatment in vitro upregulated CXCR4 and induced MSCs migration. In addition, flow cytometry demonstrated that miR-146a mimics suppressed CXCR4, and ATV pretreatment no longer ameliorated MSCs migration because of decreased CXCR4. In the AMI model, miR-146a-overexpressing MSCs increased infarct size and fibrosis.

Conclusion: The miR-146a/CXCR4 signaling pathway contributes to MSCs migration and homing induced by ATV pretreatment. miR-146a may be a novel therapeutic target for stimulating MSCs migration to the ischemic tissue for improved repair.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440697PMC
http://dx.doi.org/10.1007/s13770-021-00362-zDOI Listing

Publication Analysis

Top Keywords

mscs migration
24
atv pretreatment
12
migration
10
mscs
9
mesenchymal stem
8
cell migration
8
migration mir-146a/cxcr4
8
mir-146a/cxcr4 signaling
8
flow cytometry
8
migration ability
8

Similar Publications

Introduction: Exosomes produced by mesenchymal stem cells (MSCs) have lately garnered significant attention for their capacity to enhance wound healing. Recent studies have recognized exosomes as significant secretory products from several cell types, specifically MSCs, in regulating multiple biological processes, including wound healing. This work aims to investigate the impact of exosomes derived from the bone marrow mesenchymal stem cells (BMMSCs) of NMRI animals on keratinocyte function.

View Article and Find Full Text PDF

Purpose: Mesenchymal stem cell (MSC) therapy shows promise in preclinical ischemic stroke models, yet clinical translation remains inconsistent. To address this gap, we investigated whether labeling MSCs with Ferucarbotran enables magnetic resonance imaging (MRI) tracking and enhances neural differentiation and functional integration, particularly focusing on the novel observation of spontaneous neuronal firing activity in transplanted cells.

Methods: Rat MSCs (rMSCs) were transduced with red fluorescent protein (RFP) and labeled with Ferucarbotran to generate Fer-RFP⁺ rMSCs.

View Article and Find Full Text PDF

Exercise-Activated Mesenchymal Stem Cells: A Translational Strategy for Age-Related Sarcopenia Management.

Stem Cell Rev Rep

September 2025

Key Laboratory of Physical Fitness and Exercise Rehabilitation of Hunan Province, College of Physical Education, Hunan Normal University, Changsha, 410012, China.

Age-related Sarcopenia is a progressive, age-related disorder characterized by the loss of muscle strength, mass, and function, which is associated with an increased risk of falls and mortality and reduced quality of life, particularly in older adults. The pathophysiology of sarcopenia is complex, primarily driven by an imbalance between anabolic and catabolic muscle homeostasis. Effective interventions of sarcopenia is crucial to reverse or delay the progression of muscle disorder.

View Article and Find Full Text PDF

The interrelationship between interleukin-17 A and the immunomodulation of mesenchymal stromal cells.

Stem Cell Res Ther

September 2025

Department of Plastic and Cosmetic Surgery, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, Hainan, 570311, China.

The interaction between interleukin-17 A (IL-17 A) and mesenchymal stromal cells (MSCs), and its role in immune regulation, is a new research field with broad application potential. This review aims to elucidate the complex relationship between IL-17 A and MSCs in immune regulation, and to provide a theoretical foundation and new insights for the development of immunotherapy strategies based on MSCs in the future. The review begins by summarizing the basic characteristics of IL-17 A and the immunomodulatory function of MSCs, and then delves into the regulation of IL-17 A by MSCs and the impact of IL-17 A on the immunomodulatory effects of MSCs and its potential mechanisms.

View Article and Find Full Text PDF

Low-Intensity pulsed ultrasound enhances paracrine secretion of IGF and VEGF by bmscs, promoting osteogenesis and angiogenesis.

BMC Musculoskelet Disord

September 2025

State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, Sichuan University, Chengdu, China.

Background: Low-intensity pulsed ultrasound (LIPUS) is an effective therapy for craniofacial bone regeneration. Paracrine signaling from mesenchymal stem cells (MSCs) plays a critical role in bone repair, but the impact of LIPUS on MSC-derived secretome remains unclear. This study investigates whether LIPUS enhances the osteogenic and angiogenic potential of MSCs through modulation of growth factor secretion.

View Article and Find Full Text PDF